EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications

Isabella Salerno, Nicholas Dunn, Haley White, Wilnellys Miyazaki, Kyle Jeziorski, Delynn Silvestros, Abhinav Jha, Richard Laforest, Mercy I Akerele, M Allan Thomas, Daniel L J Thorek

Journal of Nuclear Medicine · 2026-03 · 67 (3) · 423-428

DOI: 10.2967/jnumed.125.270987 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 30.12.2025. Verfasst von Isabella Salerno und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physics Division, Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri. Hauptthemen laut MEDLINE: Precision Medicine, Radiopharmaceuticals, Neoplasms, Tomography, Emission-Computed, Single-Photon. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiopharmaceutical therapy is an emerging approach to treat metastatic disease, with the potential to enable personalized care through imaging. With the growing interest in quantitative imaging, there remains a need for systematic assessment of imageable radionuclides and scanner performance under comparable conditions. This motivated us to quantitatively and qualitatively compare SPECT and PET performance using standardized evaluation procedures to assess their effectiveness in imaging applications for targeted radiotherapy.

Methods

The National Electrical Manufacturers Association International Electrotechnical Commission body phantom was used to assess recovery coefficients, contrast, and image quality, including spatial resolution and noise. SPECT performance was evaluated using 99mTc (a low-energy γ-ray-emitting isotope), 203Pb (a surrogate for the therapeutic α-particle-emitting 212Pb), and theranostic 177Lu. PET performance was tested using 18F, 89Zr, and 64Cu as imaging surrogates.

Results

PET demonstrated superior spatial resolution and accurate activity recovery compared with SPECT, which was limited by lower sensitivity, photon scatter, and collimator design constraints. Among PET isotopes, 18F showed consistently high quantitative accuracy, whereas 89Zr and 64Cu performed similarly, with only minor reductions in performance metrics. For SPECT, 99mTc outperformed 203Pb and 177Lu in both lesion detectability and activity recovery. 203Pb and 177Lu showed poor quantitative accuracy; however, increasing iterations in reconstruction improved results.

Conclusion

These findings underscore the importance of selecting appropriate imaging modalities, isotopes, and reconstruction parameters for theranostic applications. Limitations in quantitative accuracy must be addressed and acknowledged in the search for precise and effective treatment strategies. This study also demonstrates that 203Pb may serve as a suitable diagnostic partner to 212Pb and validates the use of these quantitative methodologies for the evaluation of PET and SPECT imaging tasks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineRadiopharmaceuticalsNeoplasmsTomography, Emission-Computed, Single-PhotonPositron-Emission TomographyMolecular Targeted TherapyRadioisotopesPhantoms, ImagingSensitivity and SpecificityHumans

Stichwörter der Autor:innen

PETSPECTimage performancequantitative imagingtheranostics

Substanzen

RadiopharmaceuticalsRadioisotopes

Autor:innen und Institutionen

  • Medical Physics Division, Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
  • Program in Quantitative Molecular Therapeutics, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
  • Division of Nuclear Medicine, Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
  • Precision Radiotheranostics Translation Center, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
  • Oncologic Imaging Program, Siteman Cancer Center, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
  • Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri; and.

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Salerno, I., Dunn, N., White, H., Miyazaki, W., Jeziorski, K., Silvestros, D., Jha, A., Laforest, R., Akerele, M. I., Thomas, M. A., & Thorek, D. L. J. (2026). Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications. Journal of Nuclear Medicine, 67(3), 423-428. https://doi.org/10.2967/jnumed.125.270987

Vancouver

Salerno I, Dunn N, White H, Miyazaki W, Jeziorski K, Silvestros D, et al. Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications. Journal of Nuclear Medicine. 2026;67(3):423-428. doi:10.2967/jnumed.125.270987

BibTeX
@article{Salerno2026,
  author = {Salerno, Isabella and Dunn, Nicholas and White, Haley and Miyazaki, Wilnellys and Jeziorski, Kyle and Silvestros, Delynn and Jha, Abhinav and Laforest, Richard and Akerele, Mercy I and Thomas, M Allan and Thorek, Daniel L J},
  title = {Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {423--428},
  doi = {10.2967/jnumed.125.270987}
}
Kostenlos starten →